IBRX News
ImmunityBio, Inc.
$8.22
-$0.09(-1.08%)
--
Overall
--
Value
--
Tech
--
Quality
Market Cap
--
Volume
5.93M
52W Range
$1.95 - $12.43
Target Price
--
IBRX news: the latest ImmunityBio, Inc. headlines, press releases and market updates, newest first.
Latest IBRX News
- Analysts Offer Insights on Healthcare Companies: Evolus (EOLS), ImmunityBio (IBRX) and vTv Therapeutics (VTVT)TipRanks Newsroom · Oct 15, 2026
- ImmunityBio gains FDA expansion for ANKTIVA bladder therapyTipRanks Auto-Generated Newsdesk · Oct 14, 2026
- ImmunityBio’s New Sepsis Trial: Early-Stage Data With High-Stakes Market PotentialTipRanks Clinical-Trials-Auto-Generated Newsdesk · Sep 25, 2026
- ImmunityBio’s New Bladder Cancer Combo Trial: What Investors Should KnowTipRanks Clinical-Trials-Auto-Generated Newsdesk · Sep 24, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IBRX | $8.22 | -1.1% | 5.93M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |